Abou-Alfa GK - Search Results

1

Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.

Momtaz P, O'Connor CA, Chou JF, Capanu M, Park W, Bandlamudi C, Berger MF, Kelsen DP, Suehnholz SP, Chakravarty D, Yu KH, Varghese AM, Zervoudakis A, Li J, Ku GY, Park JS, Shcherba M, Harding JJ, Goldberg Z, Abou-Alfa GK, Salo-Mullen EE, Stadler ZK, Iacobuzio-Donahue CA, O'Reilly EM. Momtaz P, et al. Cancer. 2021 Dec 1;127(23):4393-4402. doi: 10.1002/cncr.33812. Epub 2021 Aug 5. Cancer. 2021. PMID: 34351646 Free PMC article.

2

A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.

Abou-Alfa GK, Rowinsky EK, Patt YZ, Schwartz GK, Kelsen DP, Sharma S, Siegel E, Becerra CR, Eckhardt SG, Feit K, De Jager R, O'Reilly EM. Abou-Alfa GK, et al. Am J Clin Oncol. 2005 Aug;28(4):334-9. doi: 10.1097/01.coc.0000158829.63542.2c. Am J Clin Oncol. 2005. PMID: 16062073 Clinical Trial.

3

Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.

Abou-Alfa GK, Letourneau R, Harker G, Modiano M, Hurwitz H, Tchekmedyian NS, Feit K, Ackerman J, De Jager RL, Eckhardt SG, O'Reilly EM. Abou-Alfa GK, et al. J Clin Oncol. 2006 Sep 20;24(27):4441-7. doi: 10.1200/JCO.2006.07.0201. J Clin Oncol. 2006. PMID: 16983112 Clinical Trial.

4

Cytotoxic therapy for advanced pancreatic adenocarcinoma.

O'Reilly EM, Abou-Alfa GK. O'Reilly EM, et al. Semin Oncol. 2007 Aug;34(4):347-53. doi: 10.1053/j.seminoncol.2007.05.009. Semin Oncol. 2007. PMID: 17674963 Review.

5

Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer.

O'Reilly EM, Abou-Alfa GK. O'Reilly EM, et al. Nat Clin Pract Oncol. 2008 Jun;5(6):312-3. doi: 10.1038/ncponc1128. Epub 2008 Apr 29. Nat Clin Pract Oncol. 2008. PMID: 18446142 No abstract available.

6

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR. Endo I, et al. Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3. Ann Surg. 2008. PMID: 18580211

7

Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).

Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D'Angelica M, Dematteo RP, Blumgart LH, O'Reilly EM. Duffy A, et al. J Surg Oncol. 2008 Dec 1;98(7):485-9. doi: 10.1002/jso.21141. J Surg Oncol. 2008. PMID: 18802958

8

Current management of advanced hepatocellular carcinoma.

Abou-Alfa GK, Huitzil-Melendez FD, O'Reilly EM, Saltz LB. Abou-Alfa GK, et al. Gastrointest Cancer Res. 2008 Mar;2(2):64-70. Gastrointest Cancer Res. 2008. PMID: 19259298 Free PMC article.

9

Indications for neoadjuvant, adjuvant, and palliative chemotherapy in the treatment of biliary tract cancers.

Huitzil-Melendez FD, O'Reilly EM, Duffy A, Abou-Alfa GK. Huitzil-Melendez FD, et al. Surg Oncol Clin N Am. 2009 Apr;18(2):361-79, x. doi: 10.1016/j.soc.2008.12.006. Surg Oncol Clin N Am. 2009. PMID: 19306817 Review.

10

Pancreatic islet cell carcinoma presenting with concurrent Cushing's and Zollinger-Ellison syndromes: case series and literature review.

Said R, O'Reilly EM, Blumgart L, Shia J, Abou-Alfa GK. Said R, et al. Eur J Gastroenterol Hepatol. 2010 Feb;22(2):246-52. doi: 10.1097/MEG.0b013e3283314827. Eur J Gastroenterol Hepatol. 2010. PMID: 19770666 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters